CD24 and neoplasm: One study reported CD24 expression to be the worst prognostic variable for MSGTs (prognostic data not specified per histopathological type of MSGT), significantly correlated with higher tumor size, advanced tumor stage, and positive lymph nodes [22], while another study concluded against the prognostic significance of this marker [39].